Search

Your search keyword '"Li, Wende"' showing total 28 results
Start Over Author "Li, Wende" Publisher american association for cancer research (aacr)
28 results on '"Li, Wende"'

1. Supplementary Tables 1-4 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figure 2 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Figure 5 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Figure 3 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Figure 3 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

6. Data from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure 2 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Figure 1 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figure 5 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Table S1 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

11. Supplementary Figure Legends from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

12. Supplementary Figure 6 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

13. Supplementary Figure 4 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

14. Supplementary Tables 1-4 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

15. Data from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Figure 1 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure 4 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure 6 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

19. Supplementary Figure Legends from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table S1 from DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, primary, Xiao, WeiWei, primary, Yu, Kuai, primary, Li, Shuo, primary, Yuan, Sujing, primary, Shen, Jianfei, primary, Dong, Xingjun, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Chen, Siyu, primary, Li, Wende, primary, You, Hua, primary, Xia, Xiaojun, primary, Kang, Tiebang, primary, Tan, Jing, primary, Chen, Gong, primary, Yang, An-Kui, primary, Gao, YuanHong, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity

Author

Zhang, Xiaomin, primary, Cheng, Limin, primary, Gao, Chengqi, primary, Chen, Jing, primary, Liao, Shuangye, primary, Zheng, Yongqiang, primary, Xu, Liping, primary, He, Jingjing, primary, Wang, Danyang, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Yan, Min, primary, Luan, Yi, primary, Chen, Siyu, primary, Chen, Likun, primary, Xia, Xiaojun, primary, Deng, Chunhao, primary, Chen, Guokai, primary, Li, Wende, primary, Liu, Zexian, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

22. Supplementary Data from Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy

Author

Nie, Yan, primary, Huang, Hongyan, primary, Guo, Mingyan, primary, Chen, Jiewen, primary, Wu, Wei, primary, Li, Wende, primary, Xu, Xiaoding, primary, Lin, Xiaorong, primary, Fu, Wenkui, primary, Yao, Yandan, primary, Zheng, Fang, primary, Luo, Man-Li, primary, Saw, Phei Er, primary, Yao, Herui, primary, Song, Erwei, primary, and Hu, Hai, primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity

Author

Zhang, Xiaomin, primary, Cheng, Limin, primary, Gao, Chengqi, primary, Chen, Jing, primary, Liao, Shuangye, primary, Zheng, Yongqiang, primary, Xu, Liping, primary, He, Jingjing, primary, Wang, Danyang, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Yan, Min, primary, Luan, Yi, primary, Chen, Siyu, primary, Chen, Likun, primary, Xia, Xiaojun, primary, Deng, Chunhao, primary, Chen, Guokai, primary, Li, Wende, primary, Liu, Zexian, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure 1 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity

Author

Zhang, Xiaomin, primary, Cheng, Limin, primary, Gao, Chengqi, primary, Chen, Jing, primary, Liao, Shuangye, primary, Zheng, Yongqiang, primary, Xu, Liping, primary, He, Jingjing, primary, Wang, Danyang, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Yan, Min, primary, Luan, Yi, primary, Chen, Siyu, primary, Chen, Likun, primary, Xia, Xiaojun, primary, Deng, Chunhao, primary, Chen, Guokai, primary, Li, Wende, primary, Liu, Zexian, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure 2 from Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity

Author

Zhang, Xiaomin, primary, Cheng, Limin, primary, Gao, Chengqi, primary, Chen, Jing, primary, Liao, Shuangye, primary, Zheng, Yongqiang, primary, Xu, Liping, primary, He, Jingjing, primary, Wang, Danyang, primary, Fang, Ziqian, primary, Zhang, Jianeng, primary, Yan, Min, primary, Luan, Yi, primary, Chen, Siyu, primary, Chen, Likun, primary, Xia, Xiaojun, primary, Deng, Chunhao, primary, Chen, Guokai, primary, Li, Wende, primary, Liu, Zexian, primary, and Zhou, Penghui, primary

Published
2023
Full Text
View/download PDF

26. Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Antitumor Immunity

Author

Zhang, Xiaomin, primary, Cheng, Limin, additional, Gao, Chengqi, additional, Chen, Jing, additional, Liao, Shuangye, additional, Zheng, Yongqiang, additional, Xu, Liping, additional, He, Jingjing, additional, Wang, Danyang, additional, Fang, Ziqian, additional, Zhang, Jianeng, additional, Yan, Min, additional, Luan, Yi, additional, Chen, Siyu, additional, Chen, Likun, additional, Xia, Xiaojun, additional, Deng, Chunhao, additional, Chen, Guokai, additional, Li, Wende, additional, Liu, Zexian, additional, and Zhou, Penghui, additional

Published
2023
Full Text
View/download PDF

27. DGKA Mediates Resistance to PD-1 Blockade

Author

Fu, Lingyi, primary, Li, Sen, additional, Xiao, WeiWei, additional, Yu, Kuai, additional, Li, Shuo, additional, Yuan, Sujing, additional, Shen, Jianfei, additional, Dong, Xingjun, additional, Fang, Ziqian, additional, Zhang, Jianeng, additional, Chen, Siyu, additional, Li, Wende, additional, You, Hua, additional, Xia, Xiaojun, additional, Kang, Tiebang, additional, Tan, Jing, additional, Chen, Gong, additional, Yang, An-Kui, additional, Gao, YuanHong, additional, and Zhou, Penghui, additional

Published
2021
Full Text
View/download PDF

28. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy

Author

Nie, Yan, primary, Huang, Hongyan, additional, Guo, Mingyan, additional, Chen, Jiewen, additional, Wu, Wei, additional, Li, Wende, additional, Xu, Xiaoding, additional, Lin, Xiaorong, additional, Fu, Wenkui, additional, Yao, Yandan, additional, Zheng, Fang, additional, Luo, Man-Li, additional, Saw, Phei Er, additional, Yao, Herui, additional, Song, Erwei, additional, and Hu, Hai, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results